AlloSource has introduced ReConnex Pre-Sutured Tendon, an FDA 510(k)-cleared allograft designed for all-inside anterior cruciate ligament reconstruction procedures.

ReConnex is the newest addition to the company’s AlloConnex portfolio of tendons, ligaments and fascia. The product is ready to use and pre-sutured, allowing surgeons to reduce time spent preparing tendon grafts manually in the operating room.

The device is designed to help simplify all-inside ACL reconstruction. Each ReConnex Pre-Sutured Tendon is measured under tension to ensure specified length and diameter, and is tested to meet biomechanical specifications. The product is available in diameters from 8 mm to 10.5 mm.

The clinical workflow need is clear. ACL reconstruction procedures can involve manual graft preparation steps that add time, variability and staff burden. A ready-to-use pre-sutured tendon may help standardise preparation while allowing surgical teams to focus on placement and fixation.

ReConnex also includes white loop passing sutures that allow addition of all-inside suspensory fixation. The tendon is processed using AlloSource’s AlloTrue Cleansing Process, which is designed to remove blood and lipids, reduce bioburden and preserve biomechanical properties.

The launch builds on AlloSource’s long-running role in human tissue allografts. The organisation has served the global marketplace since 1994 and works with medical professionals and biomedical companies using human tissue products for surgical and regenerative applications.